We are live on
!
Find out more
ACMC
AyurMaya Capital Management Company Portfolio holdings
AUM
$148M
1-Year Est. Return
24.4%
This Fund
S&P 500
This Quarter
Est. Return
-11.06%
1 Year Est. Return
+24.4%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$195M
AUM Growth
–
Cap. Flow
+$191M
Cap. Flow
% of AUM
97.85%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLRN
ACELYRIN
SLRN
|
+$191M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
CFO
D
SA
USWG
LAMNM
CC
MCM
CNFG
AyurMaya Capital Management Company's Q2 2023 Portfolio in Review
Q2 2023 is the first quarter with a 13F filing on record for AyurMaya Capital Management Company, which disclosed 1 position worth $195M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is ACELYRIN: 9,334,735 shares worth $195M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- AyurMaya Capital Management Company's largest Q2 2023 buy was ACELYRIN: 9,334,735 shares worth $195M.
- AyurMaya Capital Management Company's ten largest holdings make up 100% of its $195M portfolio in Q2 2023.
- AyurMaya Capital Management Company disclosed 1 position in Q2 2023, its first 13F filing on record.
Based on AyurMaya Capital Management Company's 13F filing for Q2 2023, filed 11 Aug 2023.